Cargando…

Brodifacoum does not modulate human cannabinoid receptor-mediated hyperpolarization of AtT20 cells or inhibition of adenylyl cyclase in HEK 293 cells

BACKGROUND: Synthetic cannabinoids are a commonly used class of recreational drugs that can have significant adverse effects. There have been sporadic reports of co-consumption of illicit drugs with rodenticides such as warfarin and brodifacoum (BFC) over the past 20 years but recently, hundreds of...

Descripción completa

Detalles Bibliográficos
Autores principales: Sachdev, Shivani, Boyd, Rochelle, Grimsey, Natasha L., Santiago, Marina, Connor, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6765355/
https://www.ncbi.nlm.nih.gov/pubmed/31579608
http://dx.doi.org/10.7717/peerj.7733
_version_ 1783454544181592064
author Sachdev, Shivani
Boyd, Rochelle
Grimsey, Natasha L.
Santiago, Marina
Connor, Mark
author_facet Sachdev, Shivani
Boyd, Rochelle
Grimsey, Natasha L.
Santiago, Marina
Connor, Mark
author_sort Sachdev, Shivani
collection PubMed
description BACKGROUND: Synthetic cannabinoids are a commonly used class of recreational drugs that can have significant adverse effects. There have been sporadic reports of co-consumption of illicit drugs with rodenticides such as warfarin and brodifacoum (BFC) over the past 20 years but recently, hundreds of people have been reported to have been poisoned with a mixture of synthetic cannabinoids and BFC. We have sought to establish whether BFC directly affects cannabinoid receptors, or their activation by the synthetic cannabinoid CP55940 or the phytocannabinoid Δ(9)-tetrahydrocannabinol (Δ(9)-THC). METHODS: The effects of BFC on the hyperpolarization of wild type AtT20 cells, or AtT20 cells stably expressing human CB(1)- or CB(2)- receptors, were studied using a fluorescent assay of membrane potential. The effect of BFC on CB(1)- and CB(2)-mediated inhibition of forskolin-stimulated adenylyl cyclase (AC) activation was measured using a BRET assay of cAMP levels in HEK 293 cells stably expressing human CB(1) or CB(2). RESULTS: BFC did not activate CB(1) or CB(2) receptors, or affect the hyperpolarization of wild type AtT20 cells produced by somatostatin. BFC (1 µM) did not affect the hyperpolarization of AtT20-CB(1) or AtT20-CB(2) cells produced by CP55940 or Δ(9)-THC. BFC (1 µM) did not affect the inhibition of forskolin-stimulated AC activity by CP55940 in HEK 293 cells expressing CB(1) or CB(2). BFC (1 µM) also failed to affect the desensitization of CB(1) and CB(2) signaling produced by prolonged (30 min) application of CP55940 or Δ(9)-THC to AtT20 cells. DISCUSSION: BFC is not a cannabinoid receptor agonist, and appeared not to affect cannabinoid receptor activation. Our data suggests there is no pharmacodynamic rationale for mixing BFC with synthetic cannabinoids; however, it does not speak to whether BFC may affect synthetic cannabinoid metabolism or biodistribution. The reasons underlying the mixing of BFC with synthetic cannabinoids are unknown, and it remains to be established whether the “contamination” was deliberate or accidental. However, the consequences for people who ingested the mixture were often serious, and sometimes fatal, but this seems unlikely to be due to BFC action at cannabinoid receptors.
format Online
Article
Text
id pubmed-6765355
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher PeerJ Inc.
record_format MEDLINE/PubMed
spelling pubmed-67653552019-10-02 Brodifacoum does not modulate human cannabinoid receptor-mediated hyperpolarization of AtT20 cells or inhibition of adenylyl cyclase in HEK 293 cells Sachdev, Shivani Boyd, Rochelle Grimsey, Natasha L. Santiago, Marina Connor, Mark PeerJ Biochemistry BACKGROUND: Synthetic cannabinoids are a commonly used class of recreational drugs that can have significant adverse effects. There have been sporadic reports of co-consumption of illicit drugs with rodenticides such as warfarin and brodifacoum (BFC) over the past 20 years but recently, hundreds of people have been reported to have been poisoned with a mixture of synthetic cannabinoids and BFC. We have sought to establish whether BFC directly affects cannabinoid receptors, or their activation by the synthetic cannabinoid CP55940 or the phytocannabinoid Δ(9)-tetrahydrocannabinol (Δ(9)-THC). METHODS: The effects of BFC on the hyperpolarization of wild type AtT20 cells, or AtT20 cells stably expressing human CB(1)- or CB(2)- receptors, were studied using a fluorescent assay of membrane potential. The effect of BFC on CB(1)- and CB(2)-mediated inhibition of forskolin-stimulated adenylyl cyclase (AC) activation was measured using a BRET assay of cAMP levels in HEK 293 cells stably expressing human CB(1) or CB(2). RESULTS: BFC did not activate CB(1) or CB(2) receptors, or affect the hyperpolarization of wild type AtT20 cells produced by somatostatin. BFC (1 µM) did not affect the hyperpolarization of AtT20-CB(1) or AtT20-CB(2) cells produced by CP55940 or Δ(9)-THC. BFC (1 µM) did not affect the inhibition of forskolin-stimulated AC activity by CP55940 in HEK 293 cells expressing CB(1) or CB(2). BFC (1 µM) also failed to affect the desensitization of CB(1) and CB(2) signaling produced by prolonged (30 min) application of CP55940 or Δ(9)-THC to AtT20 cells. DISCUSSION: BFC is not a cannabinoid receptor agonist, and appeared not to affect cannabinoid receptor activation. Our data suggests there is no pharmacodynamic rationale for mixing BFC with synthetic cannabinoids; however, it does not speak to whether BFC may affect synthetic cannabinoid metabolism or biodistribution. The reasons underlying the mixing of BFC with synthetic cannabinoids are unknown, and it remains to be established whether the “contamination” was deliberate or accidental. However, the consequences for people who ingested the mixture were often serious, and sometimes fatal, but this seems unlikely to be due to BFC action at cannabinoid receptors. PeerJ Inc. 2019-09-25 /pmc/articles/PMC6765355/ /pubmed/31579608 http://dx.doi.org/10.7717/peerj.7733 Text en ©2019 Sachdev et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.
spellingShingle Biochemistry
Sachdev, Shivani
Boyd, Rochelle
Grimsey, Natasha L.
Santiago, Marina
Connor, Mark
Brodifacoum does not modulate human cannabinoid receptor-mediated hyperpolarization of AtT20 cells or inhibition of adenylyl cyclase in HEK 293 cells
title Brodifacoum does not modulate human cannabinoid receptor-mediated hyperpolarization of AtT20 cells or inhibition of adenylyl cyclase in HEK 293 cells
title_full Brodifacoum does not modulate human cannabinoid receptor-mediated hyperpolarization of AtT20 cells or inhibition of adenylyl cyclase in HEK 293 cells
title_fullStr Brodifacoum does not modulate human cannabinoid receptor-mediated hyperpolarization of AtT20 cells or inhibition of adenylyl cyclase in HEK 293 cells
title_full_unstemmed Brodifacoum does not modulate human cannabinoid receptor-mediated hyperpolarization of AtT20 cells or inhibition of adenylyl cyclase in HEK 293 cells
title_short Brodifacoum does not modulate human cannabinoid receptor-mediated hyperpolarization of AtT20 cells or inhibition of adenylyl cyclase in HEK 293 cells
title_sort brodifacoum does not modulate human cannabinoid receptor-mediated hyperpolarization of att20 cells or inhibition of adenylyl cyclase in hek 293 cells
topic Biochemistry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6765355/
https://www.ncbi.nlm.nih.gov/pubmed/31579608
http://dx.doi.org/10.7717/peerj.7733
work_keys_str_mv AT sachdevshivani brodifacoumdoesnotmodulatehumancannabinoidreceptormediatedhyperpolarizationofatt20cellsorinhibitionofadenylylcyclaseinhek293cells
AT boydrochelle brodifacoumdoesnotmodulatehumancannabinoidreceptormediatedhyperpolarizationofatt20cellsorinhibitionofadenylylcyclaseinhek293cells
AT grimseynatashal brodifacoumdoesnotmodulatehumancannabinoidreceptormediatedhyperpolarizationofatt20cellsorinhibitionofadenylylcyclaseinhek293cells
AT santiagomarina brodifacoumdoesnotmodulatehumancannabinoidreceptormediatedhyperpolarizationofatt20cellsorinhibitionofadenylylcyclaseinhek293cells
AT connormark brodifacoumdoesnotmodulatehumancannabinoidreceptormediatedhyperpolarizationofatt20cellsorinhibitionofadenylylcyclaseinhek293cells